Alector Inc (ALEC)

07:52 AM

Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners - simplywall.st

07:52 AM

Apr 24, 2025

There is no way Alector Inc (ALEC) can keep these numbers up - Sete News

Apr 24, 2025

Apr 23, 2025

A Guide To The Risks Of Investing In Alector Inc (ALEC) - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

ALEC’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Neogenomics Inc (NEO) Stock’s Detailed Analysis - Marketing Sentinel

Apr 23, 2025

Apr 23, 2025

Alector Inc (ALEC): What Makes The Stock Good? - Marketing Sentinel

Apr 23, 2025

Apr 23, 2025

Gentherm Inc Is A Buy Small Cap Stock: Analysts - Marketing Sentinel

Apr 23, 2025

Apr 22, 2025

Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co. - Defense World

Apr 22, 2025

Apr 21, 2025

Alector concludes enrolment in Phase II trial of Alzheimer’s treatment - Yahoo Finance

Apr 21, 2025

Apr 18, 2025

What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - Stocksregister

Apr 18, 2025

Apr 17, 2025

Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease - GlobeNewswire

Apr 17, 2025

Apr 17, 2025

Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | ALEC Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan

Apr 17, 2025

Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India

Apr 07, 2025

Apr 04, 2025

Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 04, 2025

Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025

Apr 03, 2025

Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com

Apr 03, 2025

Apr 03, 2025

Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World

Apr 03, 2025

Mar 31, 2025

Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com

Mar 31, 2025

Mar 30, 2025

Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World

Mar 30, 2025

Mar 30, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter

Mar 30, 2025

Mar 28, 2025

Alector Announces Resignation of Chief Medical Officer - TipRanks

Mar 28, 2025

Mar 28, 2025

Alector Appoints New Chief Medical Officer - MarketScreener

Mar 28, 2025

Mar 28, 2025

Alector Provides Executive Leadership Update - The Manila Times

Mar 28, 2025

Mar 28, 2025

Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan

Mar 28, 2025

Mar 25, 2025

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace

Mar 25, 2025

Mar 21, 2025

Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Mar 21, 2025

Mar 19, 2025

Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com

Mar 18, 2025

Mar 13, 2025

Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha

Mar 13, 2025

Mar 12, 2025

Mizuho’s latest rating for ALEC stock - Knox Daily

Mar 12, 2025

Mar 11, 2025

Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India

Mar 11, 2025

Mar 10, 2025

Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Alector announces workforce reduction to cut costs - Investing.com

Mar 10, 2025

Mar 10, 2025

Alector to Cut 13% of Workforce - MarketWatch

Mar 10, 2025

Mar 10, 2025

Have Alector Insiders Been Selling Stock? - simplywall.st

Mar 10, 2025

Mar 09, 2025

Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World

Mar 09, 2025

Mar 07, 2025

Alector assumed with an Underweight at Morgan Stanley - TipRanks

Mar 07, 2025

Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India

Mar 06, 2025

Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK

Mar 06, 2025

Mar 05, 2025

Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView

Mar 05, 2025

Mar 04, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia

Mar 04, 2025

Mar 04, 2025

HC Wainwright Brokers Raise Earnings Estimates for Alector - The AM Reporter

Mar 04, 2025

Mar 03, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025